MindBio Therapeutics Corp. (CSE: MBIO)

MindBio Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Dec 20, 2024	Jun 29, 2024	Jun 29, 2023	Jun 29, 2022
Market Capitalization	3	5	-	-
Enterprise Value	7	10	-	-
Last Close Price	0.02	0.04	0.07	-
PB Ratio	-0.74	-1.01	-	-
Debt / Equity Ratio	-0.85	-0.87	-0.92	-1.06
Quick Ratio	0.02	0.03	0.13	1.17
Current Ratio	0.02	0.03	0.23	1.35
Return on Assets (ROA)	-179.00%	-91.41%	-175.93%	-
Earnings Yield	-6.42%	-7.13%	-	-
FCF Yield	-2.18%	-6.58%	-	-
Buyback Yield / Dilution	-4.59%	-20.80%	-106.14%	-
Total Shareholder Return	-4.59%	-20.80%	-106.14%	-

Source: S&P Capital IQ. Standard template. Financial Sources.